Dishman Carbogen Amcis Limited announces an Equity Buyback for INR 720 million worth of its shares.
January 16, 2020 at 02:25 pm
Share
Dishman Carbogen Amcis Limited (BSE:540701) announces a share repurchase program. Under the program, the company will repurchase up to INR 720 million worth of its shares. The shares will be repurchased at a price of INR 150 per share. The company intends to return surplus funds to the equity shareholders of the company and to help in increasing shareholder value in long term. The buyback will be funded from the balances in free reserves, current surplus and/or cash and cash equivalents, internal accruals, liquid resources and such other permissible sources of funds of the company. The program will expire on July 24, 2020. As of December 10, 2020, the company had 161,394,272 shares are issued and outstanding.
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Companyâs segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
DISHMAN CARBOGEN AMCIS LIMITED 
